缺血性卒中取栓患者白质高信号负荷研究
本研究汇总THRACE试验及两个卒中中心前瞻性队列共496例大血管闭塞急性缺血性卒中患者,回顾性分析取栓前MRI白质高信号(WMH)体积与功能预后、症状性颅内出血及再通的关系。结果显示WMH体积越大预后越差,但不影响sICH率和再通成功率;最高四分位WMH患者中仍有超过四分之一获得3个月良好预后,提示WMH负荷不应作为拒绝取栓的依据。
要点
- 取栓前WMH体积越大,90天功能预后越差(每增加1 cm³ aOR 1.05)。
- WMH严重程度与症状性颅内出血率及再通成功率均无显著关联。
- 最高WMH四分位患者中仍有28%获得良好预后,不应据此拒绝取栓。
核心结论
- 高WMH负荷的大血管闭塞急性缺血性卒中患者取栓安全性和有效性与低WMH负荷者相似,但功能预后更差。
- 最高WMH四分位患者中仍有超过四分之一获得3个月良好预后,WMH负荷不应作为拒绝取栓的理由。
研究设计与样本
- 汇总THRACE试验及两个学术综合卒中中心前瞻性队列,回顾性分析2015至2018年496例接受机械取栓的大血管闭塞急性缺血性卒中患者。
- WMH体积通过半自动平面分割法获得,分析其与90天功能独立、取栓后显著再通及症状性颅内出血的关联。
主要发现
- 496例患者中50%为女性,平均年龄68.1±15.0岁,434例(88%)存在可检测的WMH,平均体积4.93±7.7 cm³。
- WMH体积每增加1 cm³,不良预后风险增加(aOR 1.05,95%CI 1.01-1.06,p=0.014)。
- WMH严重程度与症状性颅内出血率无关(aOR 0.99,95%CI 0.93-1.04,p=0.66)。
- WMH严重程度与再通成功无关(aOR 0.99,95%CI 0.96-1.02,p=0.84)。
临床怎么用
- 对大血管闭塞急性缺血性卒中患者,取栓前WMH负荷可用于预后评估,但不应作为排除取栓的依据。
局限性
- 研究为回顾性分析,汇总试验与前瞻性队列数据可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: To determine the influence of white matter hyperintensity (WMH) burden on functional outcome, rate of symptomatic intracerebral hemorrhage (sICH), and procedural success in patients with acute ischemic stroke (AIS) treated by mechanical thrombectomy (MT) with current stentriever/aspiration devices. METHODS: Patients with AIS due to large vessel occlusion (LVO) from the Thrombectomie des Artères Cérébrales (THRACE) trial and prospective cohorts from 2 academic comprehensive stroke centers treated with MT were pooled and retrospectively analyzed. WMH volumes were obtained by semiautomated planimetric segmentation and tested in association with the rate of favorable outcome (90-day functional independence), substantial recanalization after MT, and sICH. RESULTS: A total of 496 participants were included between 2015 and 2018 (50% female, mean age 68.1 ± 15.0 years). Overall, 434 (88%) patients presented with detectable WMH (mean ± SD 4.93 ± 7.7). Patients demonstrated increasingly worse outcomes with increasing WMH volumes (odds ratio [aOR]1.05 per 1-cm3 increase for unfavorable outcome, 95% confidence interval [CI] 1.01-1.06, p = 0.014). Fifty-seven percent of patients in the first quartile of WMH volume vs 28% in the fourth quartile demonstrated favorable outcome (p < 0.001). WMH severity was not associated with sICH rate (aOR 0.99, 95% CI 0.93-1.04, p = 0.66), nor did it influence recanalization success (aOR 0.99, 95% CI 0.96-1.02, p = 0.84). CONCLUSION: Our study provides evidence that in patients with AIS due to LVO and high burden of WMH as assessed by pretreatment MRI, the safety and efficacy profiles of MT are similar to those in patients with lower WMH burden and confirms that they are at higher risk of unfavorable outcome. Because more than a quarter of patients in the highest WMH quartile experienced favorable 3 months outcome, WMH burden may not be a good argument to deny MT. CLINICALTRIALSGOV IDENTIFIER: NCT01062698.
引用
- Boulouis G, Bricout N, Benhassen W, et al. White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomy. Neurology. 2019. PMID: 31519778. doi:10.1212/WNL.0000000000008317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。